Autoantibodies to phospholipids and nuclear antigens in non-pregnant and pregnant Colombian women with recurrent spontaneous abortions
Academic Article
Autoantibodies to negatively charged phospholipids have been reported to be associated with thrombotic events, thrombocytopenia and adverse pregnancy outcome, such as intrauterine growth retardation and recurrent spontaneous abortions (RSAs). In this study, autoantibodies to 6 phospholipid antigens and antinuclear antibody (ANA) were tested in Colombian women with a history of RSAs. Sixty-eight non-pregnant and 25 pregnant women with a history of RSAs comprised the study group. Twenty-five non-pregnant normal healthy women and thirty-one normal pregnant women served as controls. The non-pregnant women with RSAs showed a higher incidence of autoantibodies to cardiolipin (23percent-flag-change positive) as compared with non-pregnant normal controls (0percent-flag-change positive; P ylt; 0.005). The incidence of autoantibodies to cardiolipin (28percent-flag-change; P ylt; 0.005), phosphatidylethanolamine (16percent-flag-change; P ylt; 0.005), phosphatidylserine (16percent-flag-change; P ylt; 0.05), phosphatidylglycerol (16percent-flag-change; P ylt; 0.05), phosphatidic acid (16percent-flag-change; P ylt; 0.01) and phosphatidylinositol (20percent-flag-change; P ylt; 0.01), in the pregnant women with RSAs was significantly higher than that of normal pregnant controls. There was no difference in the incidence of ANA in either group. In conclusion, women with a history of RSAs have a higher incidence of autoantibodies to phospholipids when compared to pregnant and normal controls. Autoimmune serological work-up is indicated during pregnancy in women with a history of RSAs.
